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KBG syndrome is a neurodevelopmental disorder, caused by dominant mutations in ANKRD11,
that is characterized by developmental delay/intellectual disability, mild craniofacial dysmorph-
isms, and short stature. Behavior and cognition have hardly been studied, but anecdotal evi-
dence suggests higher frequencies of ADHD-symptoms and social-emotional impairments. In
this study, the behavioral and cognitive profile of KBG syndrome will be investigated in order to
examine if and how cognitive deficits contribute to behavioral difficulties. A total of 18 patients
with KBG syndrome and a control group consisting of 17 patients with other genetic disorders
with comparable intelligence levels, completed neuropsychological assessment. Age-appropriate
tasks were selected, covering overall intelligence, attention, memory, executive functioning,
social cognition and visuoconstruction. Results were compared using Cohen's d effect sizes. As
to behavior, fewer difficulties in social functioning and slightly more attentional problems,
hyperactivity, oppositional defiant behavior and conduct problems were found in the KBG syn-
drome group. Regarding cognitive functioning, inspection of the observed differences shows
that patients with KBG syndrome showed lower scores on sustained attention, cognitive flexi-
bility, and visuoconstruction. In contrast, the KBG syndrome group demonstrated higher scores
on visual memory, social cognition and emotion recognition. The cognitive profile of KBG syn-
drome in this sample indicates problems in attention and executive functioning that may under-
lie the behavior profile which primarily comprises impulsive behavior. Contrary to expectations
based on previous (case) reports, no deficits were found in social cognitive functioning. These
findings are important for counseling purposes, for tailored education planning, and for the
development of personalized intervention.
KEYWORDS
ANKRD11, attention, behavior, cognition, contextual neuropsychology, executive functioning,
genetics, KBG syndrome, neurodevelopmental disorder, visuoconstruction
1 | INTRODUCTION
KBG syndrome (KBGS; OMIM #148050) is an autosomal dominant
neurodevelopmental disorder which was first described by Hermann
in 1975 and was named after the surname initials of the three families
he reported.1 The syndrome is caused by heterozygous mutations in
ANKRD11 (OMIM #611192).2 It seems likely that haploinsufficiency is
responsible for the clinical phenotype, as complete heterozygous dele-
tions of ANKRD11 have been found causative. However, recent find-
ings suggest that the pathogenesis of a heterozygous ANKRD11
mutant may also involve another mechanism, as abnormal ANKRD11
protein accumulation was observed probably caused by dimerization
of mutant and with wild-type ANKRD11.3 Although KBGS was hardly
recognized until a few years ago, a tremendous increase in molecularlyTjitske Kleefstra and Jos I.M. Egger contributed equally to this work.
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confirmed cases has been achieved after the introduction of genome-
wide sequencing technologies. So far, 218 patients have been
reported and described worldwide.2–8 Intriguingly, ANKRD11 was
identified as the most frequently mutated gene (incidence of 39) in a
cohort of 4293 patients with neurodevelopmental disorders that were
diagnosed based on whole-exome-sequencing, establishing KBG syn-
drome as one of the most prevalent dominant neurodevelopmental
syndromes.9
With regard to the somatic phenotypic presentation, KBGS is
mainly characterized by mild craniofacial dysmorphisms, macrodontia
of upper central permanent incisors, short stature and skeletal anoma-
lies. Other recognized features include cardiac abnormalities, partial
hearing loss and a persistent/large fontanel.4–7 As to neurological
findings, abnormal electroencephalogram (EEG) patterns both with
and without epileptic seizures are often described.5,6,10,11 Types of
seizures include tonic–clonic, complex partial, and absence variants
and the EEG consists mostly of non-specific slowing. Reports of neu-
roimaging show various usually mild anomalies as small cerebelli,
hypoplasia of the cerebellar vermis, enlargement of the ventricles, par-
tial agenesis of the corpus callosum, and white matter anomalies
around the ventricles and near the gray-white junction in both
hemispheres.5–8,10–12
Behavioral functioning in KBGS has primarily been described in
terms of diagnostic classifications. Series of case-studies have
reported anecdotal evidence for attention deficit hyperactivity disor-
der (ADHD), autism spectrum disorder (ASD), anxiety, as well as
aggression or compulsive behavior.4–8,10,13 The majority of studies
that included behavioral classifications did not clarify whether these
classifications were solely based on observations, or based on an
extensive diagnostic procedure. In order to substantiate the findings
regarding the psychopathology in patients with KBGS, behavioral
functioning needs to be objectified by means of multiple diagnostic
instruments, such as behavior questionnaires, clinical interviews and
systematic observations.
Cognitive functioning is closely related to behavioral functioning.
Because deficits in cognitive functioning contribute to symptoms of
behavior disorders, clarification of the underlying cognitive deficits is
essential for understanding these disorders (eg, 14,15). Insight into the
cognitive profile enables explanation of specific learning difficulties in
patients with behavior disorders and may also provide directions for
daily living, education planning and treatment of these patients. More-
over, identification of cognitive deficits may further unravel the spe-
cific contribution of ANKRD11 and its corresponding protein to
nervous system functioning and in particular to cognition. However,
virtually no studies are available that focus on cognitive functioning in
KBGS. The few studies that do address cognitive functioning in KBGS
are limited to case descriptions, mentioning evidence of intellectual
disability (ID), delayed speech and delayed motor development.5,6,8,11
Two descriptive case studies, comprising a total of four patients with
KBGS, presented additional problems in memory, executive and visuo-
spatial functioning.13,16
We recently explored cognitive abilities focusing on the strengths
and weaknesses in intelligence profiles in a larger cohort of patients
with KBGS and compared these to patients with other genetic syn-
dromes. Our results showed intelligence levels that vary from a
moderate ID to average levels of intelligence, with a majority of
patients showing mild ID.17 Furthermore, results of this study denoted
comparable intelligence profiles in patients with KBGS and patient
controls, indicating that the cognitive profile of KBGS did not include
specific weaknesses in speed of information processing or working
memory performance.17 However, as the main cognitive domains
measured by the Wechsler scales are fluid and crystallized intelli-
gence, working memory, visual processing and processing speed, and
it does not provide specific measures of, for instance, long-term mem-
ory and social cognition,18,19 examination of these domains is needed
to further delineate a cognitive profile in KBGS. Therefore the pur-
pose of this study is to thoroughly investigate both the behavioral and
cognitive profile in KBGS.
The majority of studies regarding cognitive profiling of genetic
syndromes directly compares patients' performance to normative
means or results of a healthy control group, both usually representing
individuals with an average level of intelligence.20 Because patients
with genetic syndromes often have mild to moderate ID and achieved
lower levels of education compared to the general population, such
comparison goes with a high risk of overestimation of cognitive defi-
cits in these patients, because they will probably deviate on all
domains of cognitive functioning compared to individuals with an
average level of intellectual functioning. This risk of overestimation of
cognitive deficits emphasizes the need to additionally compare cogni-
tive performance of patients with the genetic syndrome to perfor-
mances of individuals with a similar intelligence level, to enable
identification of a unique cognitive profile related to this syndrome. In
this study we perform both comparisons.
To examine how potential cognitive deficits may contribute to
the behavioral difficulties in KBGS, we will explore both the behav-
ioral and cognitive profile in KBGS. Given the findings of the previ-
ously described case studies on behavioral functioning in KBGS,
symptoms from the ADHD and ASD spectrum may be expected, as
well as anxiety, aggressive and compulsive behavior. Furthermore,
based on previous case descriptions regarding cognitive functioning,
specific deficits in memory, executive functioning and visuoconstruc-
tion are expected. To objectify these expected problems in KBGS, an
extended neuropsychological test battery that includes objective and
subjective measures as well as systematic observations, will be admin-
istered in a representative group of patients with KBGS. Performances
in this group will be compared to both normative means and to perfor-
mance of an appropriate control group, consisting of patients with
genetic syndromes other than KBGS, who also had ID and develop-
mental delay (DD).
2 | MATERIALS AND METHODS
2.1 | Participants
Forty-six participants took part in this study, including 21 patients
with a confirmed mutation in the ANKRD11 gene (KBGS group) and
25 patient genetic controls (PGC group). The latter included a mixed
group of patients with a variety of other genetic syndromes, who also
had ID/DD. Nearly every Dutch patient known with KBGS at the time
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of data collection (2015) participated in this study. The data was col-
lected simultaneously for the present study and a previous study on
intellectual profiles in KBGS.17 All participants were approached by a
clinical geneticist (T.K. or C.W.O.) at the Department of Human
Genetics of the Radboud University Nijmegen Medical Centre, The
Netherlands. The study was approved by the Central Committee on
Research Involving Human Subjects region Arnhem-Nijmegen
(NL43187.091.13). Participation was on a voluntary basis and written
informed consent was obtained from all participants or their legal
representatives.
Patients under 6 years of age, patients with an auditory or
visual handicap, or patients who were not able to speak, sit in a
chair, use a pencil or execute more than two-thirds of the cognitive
tasks, were excluded from this study. Based on these criteria, three
patients with KBGS and eight potential participants for the control
group were excluded from the study. This exclusion resulted in a
group of 18 participants with KBGS (7 males) and 17 PGC
(11 males), with a mean chronological age of respectively 18.7
(SD = 15.8, range 6-66) and 14.6 (SD = 5.6, range 6-25) years.
There was no significant group difference regarding chronological
age (t(33) = 1.02, P = 0.32, d = 0.35). The general level of intellec-
tual functioning and developmental age did not differ between
participants with KBGS and PGC (respectively t(33) = −0.45,
P = 0.65, d = 0.16 and t(27) = 0.13, P = 0.90, d = 0.05). Intelli-
gence was measured by age appropriate Wechsler scales (KBGS
group: M = 65, range 45-99) and adaptive functioning was mea-
sured by a Dutch extended interview version of the Vineland
Adaptive Behavior Scales (KBGS group: M = 7 years of age, range
3-12 years of age).
For a description of the specific genetic aberrations and medi-
cal characteristics of the participants, see Supplementary Table S1
(KBG) and Table S2 (PGC). Regarding brain development and func-
tioning in participants with KBGS, three patients had a history of
absences during early childhood; all conditions were currently in
remission. Results from neuroimaging reports in medical records,
present for eight participants with KBGS, did not show any struc-
tural anomalies. An exception was one patient with minor anoma-
lies in the left cerebellum, probably as a result of complications
during delivery. As for psychopharmacotherapy, four of the
patients received methylphenidate, one patient received risperi-
done and one patient received a combination of both types of
medications. Four participants with KBGS were first-degree rela-
tives (mother, her two daughters and her grandson). All partici-
pants with KBGS, except one, already took part in the previous
study for intelligence profiling in KBGS by the same research
group,17 and for six of these participants, the molecular and phe-
notypical characteristics have previously been reported.4 The PGC
group included a convenience sample of patients displaying vari-
ous medical anomalies, dysmorphic features, and a delayed
motor/communicative development or ID, possibly accompanied
by behavioral difficulties, who were referred on suspicion of a
genetic diagnosis to the specialized outpatient clinic of the depart-
ment of clinical genetics.
2.2 | Materials and procedure
Participants were visited at their homes by researcher LvD, psycholo-
gist, accompanied by a research assistant. Two visits of approximately
4 hours were necessary to complete the assessment for each partici-
pant, in which breaks were provided based on the individual needs of
each participant. Directly after each assessment, systematic observa-
tions of the participants were notated, with emphasis on behavioral,
attentional, executive and social functioning. For reasons of confor-
mity, a checklist based on the Test Observation Form21 was used to
scrutinize specific observational criteria such as attention span during
the assessment, motor restlessness and the quality of eye contact.
Behavioral measures included Dutch versions of multiple widely
used, gold-standard, and age appropriate behavior questionnaires to
examine the frequency and nature of behavioral difficulties and social
functioning as reported by primary caregivers (Child Behavior Check-
list, CBCL, 6-18 years of age; Strengths and Difficulties Questionnaire,
SDQ, 4-17 years of age; Children’s Social Behavior Questionnaire,
CSBQ, 4-18 years of age).
Cognitive measures included instruments that target the specific
cognitive domains of attention, memory, executive functioning,
social cognition and visuoconstruction. All tests have sufficient
norms, are well validated, and also commonly used in a variety of
international neuropsychological studies. Attention was measured
by the D2 sustained attention test (from 9 years of age), a variant of
the continuous performance test. Measures of cognitive flexibility
and planning included the Intra/Extradimensional shifting task (IED,
Cambridge Neuropsychological Test Automated Battery, CANTAB,
Cambridge Cognition, Cambridge, UK), Key search task and Zoo map
task (both part of the Behavioral Assessment of the Dysexecutive
Syndrome battery, BADS/Behavioral Assessment of the Dysexecu-
tive Syndrome battery for Children, BADS-C). The Dysexecutive
Questionnaire (DEX), Dysexecutive Questionnaire for Children
(DEX-C, 8-16 years of age) and Behavior Inventory of Executive
Functioning (BRIEF, 5-18 years of age) were used to measure the
experience of executive functioning in everyday life, as perceived by
the primary caregivers of the participants. Memory was assessed by
the Rey Auditory Verbal Learning Test (RAVLT), Rey Auditory Verbal
Learning Test for Children (RAVLT-C, 6-12 years of age), Paired
Associates Learning test (PAL) and Pattern Recognition Memory test
(PRM). Using the CANTAB, both measures of visual episodic mem-
ory and learning (PAL) and visual recognition memory (PRM) were
obtained. Social cognition was measured by performance on the
Dutch Theory of Mind test Revised (TOM-test R, from 4 years of
age), and an emotion recognition task (ERT, from 8 of age). Visual
and motor abilities including spatial and organizational components
were measured by both the Beery-Buktenica Developmental Test of
Visual-Motor Integration (Beery VMI, from 2 years of age) and the
Rey-Osterrieth Complex Figure Test (Rey CFT, from 8 years of age).
A more extensive description of the tests and their references is
included in Table S3. Both children and adults were included in this
study in order to maximize the number of participants. Therefore we
used different versions of the Wechsler scales, DEX and RAVLT in
children and adults.
VAN DONGEN ET AL. 3 of 9
2.3 | Statistical analysis
First, a comparison was made between participants with KBGS and
the norm group (healthy individuals). To this end, raw questionnaire
scores and cognitive test performance scores for all individual partici-
pants with KBGS were, directly or via the transformation of T-scores,
transformed into standardized scores. However, instead of standardiz-
ing with the KBGS group mean and SD, we used the norm group
mean and SD. The norm group refers to descriptive statistics in the
test manuals of the behavioral and cognitive tests. Additionally, for
the standardization of the score of each individual KBGS participant
we used the norm group means and SD that matched the age of the
participant (and if available also its gender and education level). This
will result in means that are not zero, while normally standardized var-
iables have a mean of zero and a SD of one.
Subsequently, behavioral difficulties and cognitive test perfor-
mances of participants with KBGS were compared to those of the
PGC, to reveal a specific behavioral and cognitive profile for partici-
pants with KBGS when taking their ID into account. Reports on all
questionnaires and performances on all above-described tests of
attention, memory, executive functioning, social cognition and visuo-
construction were compared between both groups using Cohen's
d. Although a generalized linear model would have been the prefera-
ble choice for this design, this was not feasible with a lack of power
due to the relatively small sample size compared to the large number
of dependent variables. Instead, Cohen's d effect sizes, the standard-
ized mean difference between the two groups, were calculated for all
differences in performance on cognitive tests between both
groups.22,23 Raw test scores for each questionnaire and cognitive test
were used for the calculation of Cohen's d, except for the Wechsler
scales, for which the total intelligence coefficients were used (calcu-
lated as described in the respective test manuals24,25). Cohen's d is
sensitive to outliers, therefore the presence of outliers (> 3 SD) has
been inspected. If outliers were present, both Cohen's d with and
without inclusion of the outliers were reported in the result section.
3 | RESULTS
3.1 | Behavioral functioning—questionnaires
Table 1 displays the comparison between perceived behavioral prob-
lems and social-emotional functioning compared to the norm group.
Compared to the norm group, a higher number of problems are
reported in the KBG group for all social-emotional and behavioral
functioning. The means for the total problems range between 1.05
(CBCL) and 2.21 (SDQ), with the most substantial deviations (>1.5 SD)
present in behavior problem subscales related to attention/ADHD
associated problems and social problems (>1 SD).
Table 2 displays the comparison of the KBGS and PGC group. No
relevant differences, as reflected by small effect sizes, were indicated
for the reported number of behavioral problems (SDQ, KBGS:
M = 16.56, SD = 5.00, PGC: M = 16.55, SD = 5.39; d = 0.002; CBCL,
KBGS: M = 40.63, SD = 11.26, PGC: M = 47.56, SD = 24.68; d =
− 0.38; CSBQ, KBGS: M = 33.11, SD = 15.72, PGC: M = 37.56, SD =
14.34; d = − 0.31). Furthermore, fewer problems in participants with
KBGS were also reported on the subscales of the SDQ and CBCL
related to social, affective and somatic functioning. Finally, in the
KBGS group, there was a somewhat higher number of problems in
attention (CBCL-syndrome scale: attention problems: KBGS:
M = 9.88, SD = 2.80; PGC:M = 9.33, SD = 2.83; d = 0.20) and hyper-
activity (SDQ: KBGS: M = 6.44, SD = 2.92; PGC: M = 5.55, SD =
3.42; d = 0.29) as well as oppositional defiant behavior (CBCL-
Diagnostic Statistical Manual scale: oppositional defiant problems:
KBGS: M = 3.25, SD = 2.71; PGC: M = 2.89, SD = 3.30; d = 0.43)
and conduct problems (CBCL—Diagnostic Statistical Manual scale:
conduct problems: KBGS: M = 2.25, SD = 3.37; PGC: M = 2.11, SD =
1.76; d = 0.29).
3.2 | Behavioral functioning—observations
During the assessments, participants with KBGS generally displayed a
cheerful attitude. Compared to the PGC group, participants in the
KBGS group acted more confident and displayed a tendency to brag/-
boast. A flat affect and signs of tiredness were also more frequently
present in participants with KBGS compared to PGC. Participants with
KBGS displayed fewer internalizing symptoms, such as being anxious,
worrying, being dependent on the examiner, or showing a lack of self-
confidence, compared to PGC. Almost all participants with KBGS were
initially motivated for the tasks, but were quickly under- or over stim-
ulated and displayed both performance anxiety and a low frustration
tolerance. Assessment was therefore adapted by providing more
breaks in between tasks and the use of rewards for good perfor-
mances. Hyperactive/restless behaviors were shown by one-third of
the participants with KBGS, especially the young boys, and this behav-
ior expanded when task demands increased. Hyperactive behaviors
included not being able to sit still (walking, frequent movement on a
chair or with extremities), impatience during test instructions and
excessive talking. Furthermore, participants with KBGS worked more
quickly and made more errors compared to the PGC.
3.3 | Cognitive functioning—cognitive tests
For the comparison with healthy controls, Table 1 presents the mean
differences (Z-scores) between participants with KBGS and the avail-
able norm groups for all cognitive tests. As expected, participants with
KBGS show a substantially weaker performance on all test of cogni-
tive functioning, with Z-scores ranging between - 0.79 and - 2.33. In
line with these results, there is also a higher number of perceived/sub-
jective cognitive problems, as reported by primary caregivers of the
participants (BRIEF: Z = 0.52; DEX: Z = 1.17).
Table 2 presents the mean raw scores and effect sizes for the
cognitive tests and questionnaires of the KBGS and the PGC group.
There is a slightly weaker performance in sustained attentional func-
tioning in KBGS compared to PGC (KBGS: M = 96.14, SD = 30.67;
PGC: M = 102.63, SD = 40.15; d = − 0.19). Participants with KBGS
display a different strategy compared to PGC on the sustained atten-
tion test. A description of the performance style is presented in
Table 3. In general, participants with KBGS show inhibition problems;
they tend to work faster than PGC, that is, process a higher number
of stimuli within the same time span (KBGS: M = 327.07, SD = 83.14;
4 of 9 VAN DONGEN ET AL.
PGC: M = 287.00, SD = 102, 65; d = − 0.44), but make a substantially
higher number of errors (KBGS: M = 42.14, SD = 37.68; PGC:
M = 17.69, SD = 14.45; d = − 0.91).
Furthermore, mixed results are found within the domain of execu-
tive functioning. Participants with KBGS perform weaker on a test
that measures shifting and flexibility (IED: KBGS: M = 6.78, SD =
2.51; PGC: M = 7.73, SD = 1.39; d = − 0.47) whereas there are no
relevant differences, as reflected by small effect sizes, for the perfor-
mance on tasks that measure the ability to plan and maintain overview
(Key Search: KBGS: M = 4.71, SD = 4.57; PGC: M = 3.94, SD = 4.32;
d = 0.18; Zoo map 1: KBGS: M = −1.12, SD = 6.44; PGC: M = −0.65,
SD = 5.44; d = − 0.08). Compared to PGC, participants with KBGS
seem to benefit more when structure is externally provided in a plan-
ning test (Zoo map 2: KBGS: M = 4.65, SD = 4.97; PGC: M = 3.35,
SD = 5.45; d = 0.26). As for the level of experienced problems in
executive functioning in everyday life, results indicate no relevant dif-
ferences in the number of problems between both participant groups
(BRIEF: KBGS: M = 140.33, SD = 22.27; PGC: M = 144.22, SD =
23.22; d = − 0.18; DEX: KBGS: M = 34.91, SD = 14.49; PGC:
M = 34.50, SD = 12.05; d = 0.03).
Moreover, mixed results are also found for memory functioning.
Participants with KBGS display a trend of a higher performance for
the visual memory tasks (PRM: KBGS: M = 10.50, SD = 1.25; PGC:
M = 9.67, SD = 2.02; d = 0.52; PAL: KBGS: M = 7.22, SD = 1.56;
PGC: M = 6.73, SD = 1.62; d = 0.32; PRM performance without out-
lier d = 0.65) and the delayed recall of the semantic memory task
(RAVLT: KBGS: M = 7.17, SD = 4.64; PGC: M = 6.13, SD = 3.61;
d = 0.26). The performance on the direct recall of the semantic
TABLE 1 Questionnaire and test scores KBGS group compared to norm scores
N SD
Behavior Questionnaires CSBQa 9 1.77
SDQ 8 2.21
Emotional symptoms 8 0.55
Conduct problems 8 0.76
Hyperactivity/inattention 8 1.66
Peer relations 8 1.12
CBCLa 8 1.05
SS: Anxious/depressed 8 0.64
SS: Withdrawn/depressed 8 0.68
SS: Somatic complaints 8 0.58
SS: Social problems 8 1.40
SS: Thought problems 8 0.31
SS: Attention problems 8 1.73
SS: Rule-breaking behavior 8 0.43
SS: Aggressive behavior 8 0.85
DOS: Depressive problems 8 0.53
DOS: Anxiety problems 8 0.98
DOS: Somatic problems 8 0.55
DOS: Attention deficit/hyperactivity problems 8 1.56
DOS: Oppositional defiant problems 8 0.71
DOS: Conduct problems 8 0.46
Cognition Tests WAIS-IV/WISC-IIIa 18 −2.33
D2 sustained attention testa,b 13 −0.98
Key searcha 13 −0.79
Zoo map 1a 13 −0.85
Zoo map 2a 13 −1.21
RAVLT immediate recalla,e 18 −0.94
ToM test Ra,e 18 −1.18
ERTa,c 11 −0.91
Beery VMIa 16 −1.97
Rey CFTa 14 −2.20
Questionnaires BRIEFa,b 9 0.52
DEX/DEX-Cd 11 1.17
Abbreviation: SS, syndrome scales, DOS, DSM-oriented scales.
Normative means were corrected for the following:
a Age.
b Gender.
c Years of education.
d Normative means were different for children and adults.
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TABLE 2 Questionnaire and test scores—KBGS group vs PGC group
KBG PGC
Mean Effect
N M a SD a N M a SD a Difference b Size c
Behavior Questionnaires CSBQ 9 33.11 15.72 9 37.56 14.34 −4.45 −0.31
Not optimally tuned to the social situation 9 11.00 5.70 9 7.11 5.25 3.89 0.75
Reduced contact and social interest 9 4.44 4.10 9 6.22 5.07 −1.78 −0.41
Orientation problems in time, place or
activity
9 5.89 4.08 9 8.44 2.83 −2.55 −0.77
Difficulties in understanding social
information
9 6.78 4.27 9 9.11 2.15 −2.33 −0.73
Stereotyped behavior 9 2.56 3.78 9 4.44 2.83 −1.88 −0.60
Fear of and resistance to changes 9 2.44 1.74 9 2.33 2.40 0.11 0.06
SDQ 9 16.56 5.00 11 16.55 5.39 0.01 0.002
Emotional symptoms 9 2.78 0.97 11 3.73 3.47 −0.95 −0.38
Conduct problems 9 2.00 1.58 11 1.91 1.81 0.09 0.06
Hyperactivity/inattention 9 6.44 2.92 11 5.55 3.42 0.89 0.29
Peer relations 9 2.56 3.21 11 4.64 2.20 −2.08 −0.81
Prosocial behavior 9 6.33 2.00 11 6.55 2.81 −0.22 −0.09
CBCL 8 40.63 11.26 9 47.56 24.68 −6.93 −0.38
SS: Anxious/depressed 8 4.25 2.66 9 3.89 4.81 0.36 0.10
SS: Withdrawn/depressed 8 2.25 2.38 9 3.67 3.94 −1.42 −0.46
SS: Thought problems 8 1.50 0.53 9 4.67 4.24 −3.17 −0.08
SS: Somatic complaints 8 1.75 1.39 9 2.22 2.44 −0.47 −0.25
SS: Attention problems 8 9.88 2.80 9 9.33 2.83 0.55 0.20
SS: Social problems 8 6.00 3.82 9 8.56 4.16 −2.56 −0.68
SS: Rule-breaking behavior 8 1.75 2.38 9 1.78 1.30 −0.03 −0.02
SS: Aggressive behavior 8 8.13 6.10 9 7.67 7.43 0.46 0.07
DOS: Depressive problems 8 1.88 1.55 9 3.78 4.44 −1.9 −0.59
DOS: Anxiety problems 8 3.13 2.30 9 3.56 2.74 −0.43 −0.18
DOS: Somatic problems 8 1.00 0.93 9 1.56 1.67 −0.56 −0.59
DOS: Attention deficit/hyperactivity
problems
8 8.00 2.62 9 7.33 2.24 0.67 0.18
DOS: Oppositional defiant problems 8 3.25 2.71 9 2.89 3.30 0.36 0.43
DOS: Conduct problems 8 2.25 3.37 9 2.11 1.76 0.14 0.29
Cognition Tests WAIS-IV/WISC-III 18 65.06 13.26 17 67.12 13.58 −2.06 −0.16
D2 sustained attention test 14 96.14 30.67 16 102.63 40.15 −6.49 −0.19
IED 18 6.78 2.51 15 7.73 1.39 −0.95 −0.47
Key search 17 4.71 4.57 17 3.94 4.32 0.77 0.18
Zoo map 1 17 −1.12 6.44 17 −0.65 5.44 −0.47 −0.08
Zoo map 2 17 4.65 4.97 17 3.35 5.45 1.3 0.26
RAVLT immediate recall 18 33.11 13.74 17 36.59 12.03 −3.48 −0.28
RAVLT delayed recall 18 7.17 4.64 16 6.13 3.61 1.04 0.26
PRM 18 10.50 1.25 15 9.67 2.02 0.83 0.52
PAL 18 7.22 1.56 15 6.73 1.62 0.49 0.32
ToM test R 18 26.83 6.14 16 25.00 5.96 1.83 0.31
ERT 14 48.71 10.10 14 43.93 9.08 4.78 0.52
Beery VMI 16 17.44 4.10 15 19.40 5.34 −1.96 −0.43
Beery visual 15 20.60 5.34 15 22.00 4.66 −1.4 −0.29
Beery motor 16 19.94 4.85 15 21.67 5.43 −1.73 −0.35
Rey CFT 15 14.17 8.89 15 17.73 9.31 −3.56 −0.41
Questionnaires BRIEF 9 140.33 22.27 9 144.22 23.22 −3.89 −0.18
DEX/DEX-C 11 34.91 14.49 12 34.50 12.05 0.41 0.03
Abbreviation: SS, syndrome scales, DOS, DSM-oriented scales.
a Group means and standard deviations were calculated based on the raw performance scores.
b Group differences are expressed in mean differences (mean KBGS score minus mean PGC score) and effect sizes.
c Cohen's d effect sizes of 0.2, 0.5 and 0.8 represent respectively a small, medium and large effect [22].
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performance test is, however, slightly weaker in the KBGS group com-
pared to the PGC group (RAVLT: KBGS:M = 33.11, SD = 13.74; PGC:
M = 36.59, SD = 12.03; d = − 0.28).
As for social cognitive functioning, a higher performance in the
participants with KBGS compared to the PGC group is indicated for
both social cognitive tests (ToM test R: KBGS: M = 26.83, SD = 6.14;
PGC: M = 25.00, SD = 5.96; d = 0.31; ERT: KBGS: M = 48.71, SD =
10.10; PGC: M = 43.93, SD = 9.08; d = 0.52). Lastly, there are indica-
tions for weaknesses in visuoconstruction performance in the KBGS
group (Beery VMI: KBGS: M = 17.44, SD = 4.10; PGC: M = 19.40,
SD = 5.34; d = − 0.43; Rey CFT: KBGS: M =, SD =; PGC: M =, SD =;
d = − 0.41). Weaknesses in performance were also found for visual
perception and fine motor skills (Beery Visual: KBGS: M = 20.60, SD =
5.34; PGC: M = 22.00, SD = 4.66; d = − 0.29; Beery Motor: KBGS:
M = 19.94, SD = 4.85; PGC: M = 21.67, SD = 5.43; d = − 0.35).
3.4 | Cognitive functioning—observations
Working speed during assessment appeared, in general, faster in par-
ticipants with KBGS compared to the PGC group, with signs of impul-
sivity in two boys and one girl. Attention was easily drawn in most
participants, but they differed in the level of distractibility. In females
with KBGS, two girls had moments in which they responded remark-
ably slowly; it was unclear whether this was due to deficiencies in pro-
cessing speed, attention or maybe even epileptic activity. All boys
with KBGS, except for one relatively high functioning participant,
were frequently distracted by both external and internal stimuli, and
the degree of distractibility increased during the test assessment.
4 | DISCUSSION
To the authors' knowledge, this is the first systematic investigation of
the behavioral and cognitive phenotype of KBGS using reliable and
validated assessment instruments. Comparison of the KBGS cohort to
the general population (normative means) as well as to the genetic
patient control group, pointed to a behavioral profile that includes dis-
tractibility and impulsivity. As for cognitive functioning, comparison
with normative means showed problems in all domains of cognitive
functioning, which was expected considering the fact that the pres-
ence of an ID in participants with KBGS is not sufficiently taken into
account in this comparison. Compared to the PGC group, relative
weaknesses were found for sustained attention, shifting and visuo-
construction, and relative strengths were present in memory and
social cognitive functioning.
Behavioral problems in patients with KBGS have in previous
(descriptive) studies mainly been described in terms of ADHD.5–7 In
line with these previous observations of ADHD-like symptoms, a high
level of distractibility, impulsivity and restless behavior was observed
in the participants with KBGS in this study. A slightly higher number
of these behavioral difficulties were also reported by caregivers of
participants with KBGS compared to the PGC group. Regarding affec-
tive functioning, more externalizing behavior (emotion regulation
problems, aggression as well as bragging/boasting) was observed in
the group with KBGS compared to the PGC group as well as reported
by caregivers of participants with KBGS (reflected in slightly more
conducted problems and oppositional defiant behavior). In contrast,
participants with KBGS displayed during test assessment fewer inter-
nalizing behaviors such as being anxious or worried, which fits the rel-
atively fewer reported affective problems in the KBGS group
compared to the PGC group. The first finding fits the case descrip-
tions of temper tantrums and aggression in some patients with KBGS,
whereas the latter contradicts the reports of anxious/shy behavior in
similar studies.4–7 ASD symptomatology has also been previously sug-
gested in relation to KBGS.4,6 In this study, caregivers of patients with
KBGS indeed reported more social problems. However, when the
reports of participants with KBGS were compared to an appropriate
control group with a similar level of intellectual functioning (PGC),
fewer problems in social behavior were mentioned. So there are
indeed weaknesses in social behavior in patients with KBGS, but these
problems are not considered an indication for ASD, but rather match
the level of developmental functioning.
In line with the hypotheses regarding cognition in KBGS, weak-
nesses for both executive functioning and visuoconstruction were
found in this study. More specific, comparison with the PGC group
indicated weaknesses in sustained attention, inhibition (participants
worked faster but made more errors) and cognitive flexibility. Partici-
pants with KBGS were, in contrast to the PGC group, not able to
adjust their response speed to their capabilities, which resulted in a
substantially higher number of errors in task performance. These inhi-
bition problems may also underlie their weaker visuoconstruction per-
formance. The visuoconstruction performance was not solely related
to a deficit in fine motor skills, visual perception or visuomotor inte-
gration, but rather reflected an overall weakness in these skills. The
relatively strong encoding of prominently visual (vs verbal) information
in participants with KBGS also argues against specific deficits in visual
processing. Interestingly, the insufficiencies in inhibition and shifting
were not reflected in the subjective experience of executive function-
ing as reported by the primary caregivers. Although these kind of dif-
ferences between subjective and objective findings are frequently
found, it may in this case also indicate that that the cognitive
TABLE 3 Results sustained attention test (d2)—KBGS group vs PGC group
KBG PGC
Mean Effect
Variable N M a SD a N M a SD a Difference b Size c
Number of items processed 14 327.07 83.14 16 287.00 102.65 40.07 −0.44
Number of errors 14 42.14 37.68 16 17.69 14.45 24.45 −0.91
a Group means and standard deviations are calculated based on the raw performance scores.
b Group differences are expressed in mean differences (mean KBGS score minus mean PGC score) and effect sizes.
c Cohen's d effect sizes of 0.2, 0.5 and 0.8 represent respectively a small, medium and large effect [22].
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problems in participants with KBGS are not always visible for their
caregivers, which makes it hard for them to take these weaknesses
into account in daily living.
In contrast to previously described memory deficits in case stud-
ies on KBGS,13,14 strengths in consolidation and retrieval of verbal
information were found in participants with KBGS in the current sam-
ple. Encoding of verbal information was, in contrast to imprinting of
visual information, relatively weak. These differences in memory func-
tioning might be a result of the task properties in terms of triggering
attention. The semantic test included the recurrent presentation of
auditory stimuli, and the visual test included responding to visual stim-
uli on a tablet-computer. The latter might be perceived as a game,
which could have positively affected the attention span.
This is the first study in which the (neuro)psychological pheno-
type of KBGS is extensively investigated in a substantial cohort of
patients. Only a few studies13,17 have focused on some aspects of
cognitive functioning in individual patients with KBGS before, and
studies with larger groups solely described cognitive and behavioral
functioning in terms of observations and Diagnostic Statistical Manual
classifications such as ID, ADHD or ASD.4,6 Additionally, this study
includes a suitable control group of patients with a similar level of
intellectual functioning, which is essential to explore if syndrome spe-
cific cognitive deficits may underlie the observed behavioral pheno-
type. The inclusion of such a control group is often missing in other
studies regarding cognition and behavior in genetic syndromes. None-
theless, the results should also be interpreted in light of some
limitations.
Although the cohort of this study is relatively large considering
the prevalence of known patients with KBGS in the Netherlands, the
sample size is still insufficient for regular statistical testing of signifi-
cance. The exploration of the cognitive data by inspecting effect sizes
is, however, a legitimate alternative to a multivariate analysis. Still,
caution is warranted with respect to generalization of the reported
findings. Future studies, obtaining data in multiple collaborating cen-
ters, could use the first results of this study as a starting point for fur-
ther research regarding this topic. Finally, a relatively high amount of
shared variance in cognitive tests complicates the differentiation
between the participants with KBGS and PGC. The shared variance
could be a result of floor effects; some of the cognitive tasks may
have been too difficult for a part of the patient population. As there is
still a lack of alternative cognitive tasks to reduce these floor effects,
future cognitive research should always combine traditional cognitive
assessment (measuring performance scores) with systematic observa-
tions (measuring performance processes).
Notwithstanding these limitations, the findings of this study sup-
port earlier indications for behavioral problems in patients with KBGS
that include impulsivity, restless behavior, a high level of distractibility
and impairments in emotion regulation. In psychiatric classificatory
terms, this behavior is often referred to as ADHD and psychopharma-
cological treatment strategies in patients with KBGS include as yet
both antipsychotics and psychostimulants. The effects of these drugs
on behavioral symptoms, however, have not been studied in this spe-
cific population, warranting further research on the underlying neuro-
biological cause of the restless behavior. As to the potential
underlying cognitive deficits, there are indications for problems in
sustained attention, inhibition and shifting. Contrary to expectations
based on previous (case) reports in which ASD symptomatology was
described in some patients with KBGS, no disproportional deficits
were found in social behavioral, nor social cognitive functioning in this
study. Observations confirm that performances of patients with KBGS
benefit from externally provided structure. Furthermore, patients
should be actively involved in a task, to prevent them from getting dis-
tracted, which seems crucial for learning and development in KBGS.
In conclusion, the above described findings highlight the impor-
tance of in-depth evaluations of the neuropsychological profile of
individual patients with KBGS (with a correction for the level of intelli-
gence) both for counseling purposes, for tailoring education planning,
and for the development of personalized treatment.
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